Evaluation of suspected urinary tract infection in ambulatory women: A cost-utility analysis of office-based strategies

Henry C. Barry, Mark H. Ebell, John Hickner

Research output: Contribution to journalArticle

81 Citations (Scopus)

Abstract

BACKGROUND. The purpose of this study was to determine the most cost- effective strategy for managing suspected urinary tract infections in otherwise healthy adult women presenting to their primary care physician with dysuria and no symptoms or signs of pyelonephritis. Several office-based management strategies are considered: empiric therapy, use of dipstick analysis, use of complete urinalysis, and several strategies using office or laboratory cultures. METHODS. We constructed a decision tree using model probabilities obtained from the literature. Where published probabilities were unavailable, we used extensive sensitivity analyses. Utilities were obtained from the Index of Well-Being. We obtained costs by surveying hospitals, physicians, and pharmacies. RESULTS. The most cost-effective strategy is to treat empirically ($71.52 per quality-adjusted life month, QALM). When the cost of antibiotics exceeds $74.50 or if the prior probability of having a UTI is under 0.30, then treatment guided by the results of a complete urinalysis is preferred. While it was the preferred strategy, other strategies (complete urinalysis, culture and treat, and dipstick testing only) were associated with greater utility. The marginal cost-effectiveness of these strategies compared with empiric therapy ranged from $2964 to $48,460 per additional QALM. CONCLUSIONS. The preferred strategy of empiric therapy is robust over a wide range of sensitivity analyses. While empiric therapy is associated with the best cost-utility ratio, doing a culture yields the greatest utility at greater incremental cost per QALM. Many primary care physicians already treat UTIs empirically with antibiotics. This study confirms that empiric therapy, while frowned upon by some, is a cost-effective strategy. Other strategies may be considered, but at greater marginal cost. Ultimately these findings need to be confirmed in clinical trials.

Original languageEnglish (US)
Pages (from-to)49-60
Number of pages12
JournalJournal of Family Practice
Volume44
Issue number1
StatePublished - Jan 1 1997
Externally publishedYes

Fingerprint

Urinary Tract Infections
Cost-Benefit Analysis
Costs and Cost Analysis
Urinalysis
Quality of Life
Primary Care Physicians
Therapeutics
Office Management
Anti-Bacterial Agents
Dysuria
Decision Trees
Hospital Costs
Pharmacies
Pyelonephritis
Signs and Symptoms
Clinical Trials
Physicians

Keywords

  • cost- benefit analysis
  • decision trees
  • female
  • treatment outcomes
  • Urinary tract infections

ASJC Scopus subject areas

  • Family Practice

Cite this

Evaluation of suspected urinary tract infection in ambulatory women : A cost-utility analysis of office-based strategies. / Barry, Henry C.; Ebell, Mark H.; Hickner, John.

In: Journal of Family Practice, Vol. 44, No. 1, 01.01.1997, p. 49-60.

Research output: Contribution to journalArticle

@article{061ef6dbdbb54963abc6e2aecec30012,
title = "Evaluation of suspected urinary tract infection in ambulatory women: A cost-utility analysis of office-based strategies",
abstract = "BACKGROUND. The purpose of this study was to determine the most cost- effective strategy for managing suspected urinary tract infections in otherwise healthy adult women presenting to their primary care physician with dysuria and no symptoms or signs of pyelonephritis. Several office-based management strategies are considered: empiric therapy, use of dipstick analysis, use of complete urinalysis, and several strategies using office or laboratory cultures. METHODS. We constructed a decision tree using model probabilities obtained from the literature. Where published probabilities were unavailable, we used extensive sensitivity analyses. Utilities were obtained from the Index of Well-Being. We obtained costs by surveying hospitals, physicians, and pharmacies. RESULTS. The most cost-effective strategy is to treat empirically ($71.52 per quality-adjusted life month, QALM). When the cost of antibiotics exceeds $74.50 or if the prior probability of having a UTI is under 0.30, then treatment guided by the results of a complete urinalysis is preferred. While it was the preferred strategy, other strategies (complete urinalysis, culture and treat, and dipstick testing only) were associated with greater utility. The marginal cost-effectiveness of these strategies compared with empiric therapy ranged from $2964 to $48,460 per additional QALM. CONCLUSIONS. The preferred strategy of empiric therapy is robust over a wide range of sensitivity analyses. While empiric therapy is associated with the best cost-utility ratio, doing a culture yields the greatest utility at greater incremental cost per QALM. Many primary care physicians already treat UTIs empirically with antibiotics. This study confirms that empiric therapy, while frowned upon by some, is a cost-effective strategy. Other strategies may be considered, but at greater marginal cost. Ultimately these findings need to be confirmed in clinical trials.",
keywords = "cost- benefit analysis, decision trees, female, treatment outcomes, Urinary tract infections",
author = "Barry, {Henry C.} and Ebell, {Mark H.} and John Hickner",
year = "1997",
month = "1",
day = "1",
language = "English (US)",
volume = "44",
pages = "49--60",
journal = "Journal of Family Practice",
issn = "0094-3509",
publisher = "Appleton-Century-Crofts",
number = "1",

}

TY - JOUR

T1 - Evaluation of suspected urinary tract infection in ambulatory women

T2 - A cost-utility analysis of office-based strategies

AU - Barry, Henry C.

AU - Ebell, Mark H.

AU - Hickner, John

PY - 1997/1/1

Y1 - 1997/1/1

N2 - BACKGROUND. The purpose of this study was to determine the most cost- effective strategy for managing suspected urinary tract infections in otherwise healthy adult women presenting to their primary care physician with dysuria and no symptoms or signs of pyelonephritis. Several office-based management strategies are considered: empiric therapy, use of dipstick analysis, use of complete urinalysis, and several strategies using office or laboratory cultures. METHODS. We constructed a decision tree using model probabilities obtained from the literature. Where published probabilities were unavailable, we used extensive sensitivity analyses. Utilities were obtained from the Index of Well-Being. We obtained costs by surveying hospitals, physicians, and pharmacies. RESULTS. The most cost-effective strategy is to treat empirically ($71.52 per quality-adjusted life month, QALM). When the cost of antibiotics exceeds $74.50 or if the prior probability of having a UTI is under 0.30, then treatment guided by the results of a complete urinalysis is preferred. While it was the preferred strategy, other strategies (complete urinalysis, culture and treat, and dipstick testing only) were associated with greater utility. The marginal cost-effectiveness of these strategies compared with empiric therapy ranged from $2964 to $48,460 per additional QALM. CONCLUSIONS. The preferred strategy of empiric therapy is robust over a wide range of sensitivity analyses. While empiric therapy is associated with the best cost-utility ratio, doing a culture yields the greatest utility at greater incremental cost per QALM. Many primary care physicians already treat UTIs empirically with antibiotics. This study confirms that empiric therapy, while frowned upon by some, is a cost-effective strategy. Other strategies may be considered, but at greater marginal cost. Ultimately these findings need to be confirmed in clinical trials.

AB - BACKGROUND. The purpose of this study was to determine the most cost- effective strategy for managing suspected urinary tract infections in otherwise healthy adult women presenting to their primary care physician with dysuria and no symptoms or signs of pyelonephritis. Several office-based management strategies are considered: empiric therapy, use of dipstick analysis, use of complete urinalysis, and several strategies using office or laboratory cultures. METHODS. We constructed a decision tree using model probabilities obtained from the literature. Where published probabilities were unavailable, we used extensive sensitivity analyses. Utilities were obtained from the Index of Well-Being. We obtained costs by surveying hospitals, physicians, and pharmacies. RESULTS. The most cost-effective strategy is to treat empirically ($71.52 per quality-adjusted life month, QALM). When the cost of antibiotics exceeds $74.50 or if the prior probability of having a UTI is under 0.30, then treatment guided by the results of a complete urinalysis is preferred. While it was the preferred strategy, other strategies (complete urinalysis, culture and treat, and dipstick testing only) were associated with greater utility. The marginal cost-effectiveness of these strategies compared with empiric therapy ranged from $2964 to $48,460 per additional QALM. CONCLUSIONS. The preferred strategy of empiric therapy is robust over a wide range of sensitivity analyses. While empiric therapy is associated with the best cost-utility ratio, doing a culture yields the greatest utility at greater incremental cost per QALM. Many primary care physicians already treat UTIs empirically with antibiotics. This study confirms that empiric therapy, while frowned upon by some, is a cost-effective strategy. Other strategies may be considered, but at greater marginal cost. Ultimately these findings need to be confirmed in clinical trials.

KW - cost- benefit analysis

KW - decision trees

KW - female

KW - treatment outcomes

KW - Urinary tract infections

UR - http://www.scopus.com/inward/record.url?scp=0031031442&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031031442&partnerID=8YFLogxK

M3 - Article

C2 - 9010371

AN - SCOPUS:0031031442

VL - 44

SP - 49

EP - 60

JO - Journal of Family Practice

JF - Journal of Family Practice

SN - 0094-3509

IS - 1

ER -